StockNews.AI
PLTR
StockNews.AI
103 days

The Joint Commission and Palantir Technologies Announce Strategic Partnership to Elevate Patient Safety and Healthcare Standards

1. Palantir partners with The Joint Commission to enhance healthcare accreditation data. 2. Collaboration aims to improve operational efficiency and patient outcomes significantly. 3. Utilizing AI, this partnership targets better clinical processes and performance metrics. 4. Palantir's previous healthcare innovations have notably reduced patient wait times. 5. The partnership supports quality and safety standards for over 80% of U.S. hospitals.

7m saved
Insight
Article

FAQ

Why Bullish?

The partnership could substantially boost Palantir's revenue through expansive healthcare applications, similar to previous contract deals that positively impacted stock performance.

How important is it?

The partnership represents a significant market expansion opportunity in healthcare, indicating high potential for increased revenue and stock value.

Why Long Term?

The long-term nature of the partnership indicates sustained growth prospects, much like previous strategic alliances with healthcare giants that have taken time to mature.

Related Companies

Cleveland ClinicTampa GeneralNEECSCO
OAKBROOK TERRACE, Illinois, and DENVER, May 08, 2025 (GLOBE NEWSWIRE) -- The Joint Commission and Palantir Technologies announced today a long-term strategic partnership aimed at revolutionizing how healthcare organization and accreditation data are gathered and utilized. This will support healthcare organizations in benchmarking quality and improving outcomes. By leveraging Palantir’s cutting-edge data analytics and artificial intelligence, this collaboration will allow both The Joint Commission and healthcare organizations to increase operational efficiency in the management of quality standards for accreditation and certification, supporting hospitals and healthcare organizations in delivering the highest – and safest – level of patient care. “Leveraging AI and advanced data analytics will help us better understand the links between the care process and measured outcomes necessary for a step change in clinical operations and performance,” says Jonathan B. Perlin, MD, PhD, president and CEO of The Joint Commission. “Palantir’s emerging leadership in healthcare transformation make them the ideal partner to support data-driven improvement and agile product development that reduces provider burden and enhances the quality of patient care.” As the global leader in setting meaningful standards for healthcare quality and safety, including for over 80 percent of U.S. hospitals, The Joint Commission will collaborate with Palantir Technologies to apply their next-generation AI platform to the accreditation and certification process. This initiative will streamline these processes, resulting in improved patient outcomes, enhanced safety protocols, and an enriched experience for both healthcare providers and patients. “The Joint Commission is committed to building the accreditation and certification process of the future, today,” says Alex Karp, co-founder and chief executive officer of Palantir Technologies. “This work will improve global health outcomes by utilizing AI to drive performance improvements around the world.” Palantir’s approach is already having a significant impact on the healthcare industry with their innovation supporting institutions including the Cleveland Clinic, Tampa General, and Nebraska Medicine, among many additional healthcare systems across the country. The integration of AI has led to reductions in patient wait times, improvements in clinical decision-making, and streamlined reimbursement processes, thus enhancing overall patient satisfaction and outcomes. “Through our partnership with Palantir, we have seen significant improvement in care coordination, clinical outcomes and the patient experience,” says John Couris, President and CEO of Tampa General Hospital. “Given the scale and reach of The Joint Commission, I’m excited to see more of these success stories across the industry to achieve better healthcare outcomes for all.” ### About The Joint Commission Founded in 1951, The Joint Commission seeks to continuously improve healthcare for the public, in collaboration with other stakeholders, by evaluating healthcare organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies more than 23,000 healthcare organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation’s oldest and largest standards-setting and accrediting body in healthcare. Learn more about The Joint Commission at www.jointcommission.org. About Palantir Technologies Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir's expectations regarding the expected benefits of Palantir's software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond Palantir's control. These risks and uncertainties include the ability to meet the unique needs of customers; the failure of Palantir's platforms to satisfy customers or perform as desired; the frequency or severity of any software and implementation errors; Palantir's platforms’ reliability; and customers' ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings Palantir makes with the Securities and Exchange Commission from time to time. Except as required by law, Palantir does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

Related News